It will be of particular interest to learn whether combination therapy with effective CFTR modulators (68, 69) could prevent or slow the fragmentation of the CF airway metagenome in preschool children, when its composition is closest to that in healthy lungs (50, 65). This evidence concerns the gene CFTR and cystic fibrosis.